Siva Vijayakumar Tharumasivam | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Citation Awards

Siva Vijayakumar Tharumasivam | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Dr.Siva Vijayakumar Tharumasivam, Dhanalakshmi Srinivasan University, India

Dr. T. Siva Vijayakumar (M.Sc., Ph.D., D.Sc. Honoris Causa) is a dedicated academician and accomplished researcher in Biotechnology, currently serving as Associate Dean – HRDC at Dhanalakshmi Srinivasan University, Tamil Nadu. With a dual role as Flying Officer in the Indian NCC (Airwing), his career embodies leadership in both academia and service. Dr. Vijayakumar’s dynamic research covers aquatic toxicology, nanobiotechnology, neurodegenerative diseases, and regenerative medicine. He has guided numerous students in pioneering scientific exploration and has authored over 48 publications in reputed journals. A passionate mentor, he integrates innovative methodologies in research and education, ensuring his students gain holistic scientific exposure. His expertise has earned national recognition, contributing to scientific knowledge and societal progress. Committed to sustainable solutions, his work addresses pressing environmental and health challenges through nanoscience and biotechnology. His impactful contributions continue to inspire emerging scientists and institutions alike. 🌿🔬🇮🇳

Publication Profile

google scholar

Education

Dr. Siva Vijayakumar pursued his Master of Science (M.Sc.) in Biotechnology, followed by a Doctor of Philosophy (Ph.D.), with an academic journey grounded in molecular biology, toxicology, and applied nanoscience. Recognized for his significant contributions to the field, he was conferred with a Doctor of Science (D.Sc.) Honoris Causa by the International Agency for Standards and Rating in 2021. His education reflects a strong emphasis on multidisciplinary integration, blending core biological sciences with technological innovations. He has continually upgraded his scientific expertise through hands-on research, workshops, and training programs. His educational foundation has enabled him to bridge theoretical knowledge with practical applications in fields such as drug delivery, aquatic environmental health, and regenerative biology. Through his academic pursuits, he has mentored future scientists, instilling a rigorous yet innovative approach to biotechnology. 📘🧬🎓

Experience

Dr. Vijayakumar has over a decade of teaching and research experience in biotechnology. Currently, he holds the position of Associate Dean – Human Resource Development Centre (HRDC) at the Department of Biotechnology, Dhanalakshmi Srinivasan University, Tamil Nadu. He also serves as a Flying Officer and Associate NCC Officer (3TN Air Squadron NCC, Trichy), promoting discipline and patriotism among students. His academic leadership spans curriculum development, research mentoring, and interdisciplinary program coordination. He has played a pivotal role in conducting national workshops, guiding research scholars, and collaborating on funded projects. His administrative experience has fortified institutional growth through strategic planning and research integration. As a faculty member and leader, he’s known for fusing technology with biological sciences, emphasizing innovation, and cultivating global scientific perspectives among students. 🧪📚✈️

Awards and Honors

Dr. Siva Vijayakumar has been honored with several prestigious awards recognizing his excellence in research and education. Notable among them is the Guru Samman Award 2025 🧑‍🏫 by AISPCPA, Bengaluru, and the Innovative Research Award 2023 🧠 by Rover Agricultural College, Perambalur. In 2021, he received the Honorary Doctorate in Biotechnology (D.Sc.) 🎓 and the Research Excellence Award 🏆 by the Institute of Scholars. His early research acumen earned him the Young Investigator Award 2020 🔍 from DERO and the Best Young Scientist Award 2017 🧬 by PEARL Foundation. These accolades reflect his dedication to advancing biotechnology, inspiring students, and contributing meaningfully to scientific society. His recognition across both academic and service domains illustrates a career committed to innovation, leadership, and impact. 🌟🏅

Research Focus

Dr. Vijayakumar’s primary research revolves around Aquatic Toxicology and Nanobiotechnology, emphasizing the impact of engineered nanomaterials (ENMs) on aquatic ecosystems. He investigates the toxicity, transport, bioaccumulation, and ecological impact of nanoparticles, including their genotoxic and ecotoxic consequences. His research extends to drug delivery systems, exploring biocompatibility, host responses, and novel therapeutics for neurodegenerative diseases and tissue regeneration. His interdisciplinary approach bridges molecular biology, environmental science, and materials engineering. A strong advocate for eco-safe nanotechnology, he integrates in vitro, in vivo, and computational models to assess risk and functionality. His team engages in animal model studies, molecular simulations, and regenerative biomaterial design, contributing to innovations in environmental health and biomedical applications. His vision is to foster sustainable and safe biotechnological advancements for future healthcare and environmental well-being. 🌊🧪🧠

Publication Top Notes

  1. 🧬 Exploring Piperine as a Potential Treatment for Polycystic Ovarian Syndrome: Insights from In-silico Docking Studies (2024)

  2. 🐟 Toxicity Assessment on Haematology and Enzymological Alterations of Al₂O₃ Nanoparticles Exposed Freshwater Fish (2024)

  3. 🌿 Exploring Potential Anti-aging Compounds and Binding Affinity of Resveratrol with hTERT Gene (2024)

  4. 🧠 Computational Analysis of Anti-Alzheimer’s Efficacy of Myristicin from Nutmeg (2024)

  5. 🧫 Characterization of Novel Antimicrobial Peptides from Clarias Batrachus (2024)

  6. 💧 Carbon Nanoparticles Fabricated Microfilm for Microplastics Filtration (2023)

  7. 🩹 Functional 2D Graphene Oxide in the Wound Healing Process (2023)

  8. 🦐 Probiotics-Infused Withania Somnifera for Shrimp Development (2023)

  9. 🧪 Fabrication of Silver Nanoparticles using Illicium Verum and Its Anti-bacterial Activity (2023)

  10. 🍇 Pharmacological Properties and Mode of Action of Quercetin: A Bioactive Flavonoid (2023)

  11. 🌱 Anti-inflammatory Activity of Ocimum Tenuiflorum-loaded Chitosan Nanoparticles (2023)

  12. 🧬 Complete Overview of Enzymatic Responses in Nanoparticle-Stressed Fish Models (upcoming)

William Agbozo | Biochemistry, Genetics and Molecular Biology | Best Research Article Award

Published on by Citation Awards

William Agbozo | Biochemistry, Genetics and Molecular Biology | Best Research Article Award

William Agbozo, Morehouse School of Medicine, Atlanta, GA 30310, USA. United States

William Kwaku Agbozo is a passionate Ghanaian biomedical researcher specializing in molecular and cell biology, particularly in the context of hemolysis-related complications in sickle cell disease and cerebral malaria. With a strong academic foundation from the University of Ghana, he has cultivated expertise through interdisciplinary training in physiology, biochemistry, and molecular sciences. Currently serving as a Research Scholar at Morehouse School of Medicine, Atlanta, he brings his research to life by utilizing advanced genomics and proteomics tools in both animal and human studies. His work has yielded peer-reviewed publications and international presentations, reflecting a commitment to translational science aimed at uncovering therapeutic targets. William has also made significant contributions as a lecturer at Central University, Ghana, mentoring students and guiding research projects. His career is driven by a desire to bridge clinical gaps in infectious and genetic diseases, focusing on real-world biomedical challenges in Africa and beyond.

Publication Profile

orcid

Education

William Agbozo’s academic journey began at the University of Ghana, where he earned his Bachelor of Science in Biochemistry (2008–2012). He continued at the same institution to pursue a Master of Philosophy in Physiology (2013–2015), equipping him with in-depth knowledge of human physiological mechanisms. Motivated by a growing interest in translational biomedical research, he embarked on a PhD in Molecular and Cell Biology (2018–2024, Viva pending), also at the University of Ghana. Throughout his academic path, William has maintained a strong interdisciplinary focus—integrating molecular biology, physiology, and cell biology with practical research on diseases like sickle cell and malaria. His PhD was conducted under the prestigious West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), supported by multiple international grants, where he gained valuable skills in omics technologies and disease modeling. His academic training reflects both scientific rigor and a deep-rooted commitment to addressing health burdens in Africa.

Experience

William Agbozo has over six years of academic and research experience. From 2017 to 2023, he worked as a Lecturer at the School of Medicine and Health Sciences, Central University, Accra, where he taught undergraduate physiology and supervised research and academic writing. In 2023, he transitioned to the Morehouse School of Medicine in Atlanta, USA, as a Research Scholar in the Department of Microbiology, Biochemistry & Immunology. At Morehouse, he is engaged in conceptualizing research ideas, contributing to grant proposals, and conducting laboratory experiments in molecular and translational research. He also leads data analysis and presents at major scientific meetings. His work spans across both African and U.S.-based biomedical institutions, reinforcing a global collaborative perspective. His experience reflects a balance of education, research, mentorship, and scientific communication, aimed at producing actionable insights for health systems managing genetic and infectious diseases.

Awards and Honors

William Agbozo has received several prestigious awards in recognition of his academic excellence and impactful research. He was awarded a PhD Fellowship (2018–2024) from the West African Centre for Cell Biology of Infectious Pathogens (WACCBIP) under the World Bank African Centres of Excellence (ACE) initiative. Between 2019 and 2023, he secured research funding support from the Sickle Cell Disease Genomics Network of Africa (SickleGenAfrica), funded by the National Heart, Lung, & Blood Institute (U54HL141011). His scientific aptitude also earned him a place in the US Exchange Visitor Program as a research scholar at Morehouse School of Medicine (2023–2025), under the National Institute of Neurological Disorders and Stroke (R01NS125775). These honors reflect both his research potential and his growing international reputation in the fields of sickle cell disease and molecular medicine. They have empowered him to explore groundbreaking discoveries using both human samples and experimental models.

Research Focus

William Agbozo’s research centers on the molecular mechanisms of hemolysis-mediated injury in diseases such as sickle cell disease (SCD) and human cerebral malaria (HCM). His work investigates how excess free heme contributes to acute kidney injury (AKI) and brain damage, using humanized sickle cell mouse models and post-mortem human samples. He applies cutting-edge genomics and proteomics to map signaling pathways and identify biomarkers that may serve as protective or therapeutic targets. Through his research, William aims to bridge molecular biology with translational applications, developing insights that could lead to novel treatments or interventions. His work is especially impactful in regions heavily burdened by malaria and genetic blood disorders. By collaborating across institutions in Ghana and the United States, he brings an interdisciplinary and international lens to pressing biomedical problems affecting both African and global populations.

Publication Top Notes

📄 Hydroxyurea Mitigates Heme-Induced Inflammation and Kidney Injury in Humanized Sickle Cell Mice. (2025)
📄 Circulating biomarkers associated with pediatric sickle cell disease. (2024)
📄 Assessing knowledge of sickle cell disease and health beliefs on premarital genetic screening among healthcare trainees at a tertiary institution: A cross‐sectional study. (2023)
📄 Sociodemographic and medical characteristics of liver cirrhosis deaths in a Ghanaian tertiary hospital. (2022)
📄 Phosphomolybdenum Blue Detection – A Review of Characteristics, Achievements, Challenges and Future Prospects. (2020)
📄 Frequencies and ethnic distribution of ABO and RhD blood groups in the Volta region of Ghana, towards effective blood bank services. (2022)
📄 Frequency of ABO/Rhesus (D) blood groupings and ethnic distribution in the Greater‐Accra region of Ghana, towards effective blood bank inventory. (2019)
📄 Neuregulin-1 attenuates hemolysis-mediated kidney injury in humanized sickle cell mice. (Submitted)

Mohamed Taha | Biochemistry | Best Researcher Award

Published on by Citation Awards

Mohamed Taha | Biochemistry | Best Researcher Award

Dr Mohamed Taha, National Research Center, Egypt

Dr. Mohamed Taha is a distinguished biophysicist and molecular biologist 🧬 with over 20 years of academic and research experience across Egypt, Germany, and the USA 🌍. He earned his Ph.D. in Natural Sciences (Biology) from Heinrich-Heine University, Germany 🇩🇪, under a DAAD scholarship, achieving Magna Cum Laude honors 🎓. His multidisciplinary expertise spans biochemistry, neurodegeneration, proteomics, and gene editing technologies like CRISPR/Cas9 🔬. Dr. Taha has led innovative research projects on oxidative stress and Alzheimer’s disease 🧠, protein networks related to Fragile X syndrome, and molecular biomarkers for autism. Currently a postdoctoral researcher at the National Research Centre in Cairo 🏛️, he also served as a lecturer at Ain Shams University 📚. With an impressive track record of international collaborations, publications in high-impact journals, and cutting-edge research methods, Dr. Taha exemplifies excellence in scientific inquiry, mentorship, and translational medicine. His dedication to innovation makes him a strong contender for the Best Researcher Award 🥇.

Publication Profile

Scopus

Education 

Dr. Mohamed Taha holds a Ph.D. in Biology (Natural Sciences) from the Institute of Biochemistry and Molecular Biology II, Faculty of Medicine, Heinrich-Heine University, Düsseldorf, Germany 🇩🇪 (2009–2014), graduating with Magna Cum Laude distinction 🎓. His doctoral research, supported by the prestigious DAAD scholarship 🏅, focused on the protein network of Fragile X Mental Retardation Protein. He earned an M.Sc. in Biophysics from Ain Shams University, Cairo 🇪🇬 (2003–2007), where he studied gene expression in hearing-impaired children 🧬. Prior to that, he completed his B.Sc. in Biophysics from the same university (1997–2001), graduating with high honors 📘. His diverse educational background combines advanced training in molecular biology, proteomics, biochemistry, and biophysics 🔬. This academic foundation has propelled Dr. Taha into the forefront of international biomedical research and has enabled him to work across multidisciplinary scientific domains with depth and innovation 🧠🔍.

Experience 

Dr. Mohamed Taha brings a rich tapestry of research and teaching experience across international institutions 🌐. Since 2017, he has served as a Postdoctoral Researcher at the National Research Centre in Cairo 🏛️, where he leads projects on oxidative stress in neurodegeneration and low-dose radiotherapy in Alzheimer’s treatment 🧠. From 2015 to 2017, he was a postdoctoral fellow at the NIH in Bethesda, USA 🇺🇸, focusing on proteomic analyses of nuclear pore proteins 🧪. He also worked at Heinrich-Heine University, Germany 🇩🇪 (2014–2015), researching protein networks in Fragile X syndrome. Earlier, he contributed as a lecturer at Ain Shams University (2018–2021) 📚 and as a research assistant and assistant researcher at the National Research Centre (2003–2009). His hands-on lab experience spans molecular cloning, gene editing (CRISPR), microscopy, chromatography, and biophysical techniques, alongside strong teaching and mentoring roles 🔬👨‍🏫.

Awards and Honors

Dr. Taha has an impressive academic journey, starting with a DAAD Scholarship (2009–2014) that provided full funding for his Ph.D. at Heinrich-Heine University, Germany, where he graduated magna cum laude for his exceptional research in biology. He furthered his career with a tenure-track position as a postdoctoral researcher at the National Research Centre in Cairo, followed by an NIH Postdoc Fellowship in the USA (2015–2017). During this time, he also mentored NIH summer students, earning recognition for his guidance. Dr. Taha served as a University Lecturer at Ain Shams University, teaching undergraduate biotechnology from 2018 to 2021. His contributions to neurobiology, proteomics, and molecular diagnostics have earned him a nomination for the Best Researcher Award. His dedication to research and mentoring, coupled with his global academic recognition, showcases his commitment to advancing the scientific community, making him a deserving candidate for further honors and accolades. 🌍🧬📚

Research Focus

Dr. Mohamed Taha’s research bridges molecular biology, neurodegeneration, and proteomics 🧬🧠. His Ph.D. work provided novel insights into Fragile X Mental Retardation Protein (FMRP), a key regulator of neuronal function and synaptic plasticity 💡. At NIH, he advanced proteomic approaches to analyze nuclear pore protein modifications during mitosis 🧫. Currently, he investigates oxidative stress and low-dose radiotherapy as therapeutic strategies for neurodegenerative diseases, especially Alzheimer’s 🧠⚡. He also explores genetic and biochemical markers in autism and viral diseases. His methodologies span CRISPR/Cas9 gene editing, confocal microscopy, flow cytometry, ELISA, FPLC protein purification, and real-time PCR 🔍. With a focus on translational research and early biomarker discovery, Dr. Taha’s work aims to bridge the gap between lab innovations and clinical applications, addressing unmet medical needs and contributing significantly to precision medicine 🌟🧪.

Publication Top Notes

  • Fragile X Messenger Ribonucleoprotein Protein and Its Multifunctionality: From Cytosol to Nucleolus and Back (Biomolecules, 2024)

  • 🦠 In Vitro Assessment of a Natural Monoterpene as an Antiviral Compound against Low Pathogenic Human Coronavirus 229E (Egypt. J. Chem., 2024)

  • 🔄 Physical Interaction between ERas and Arginase-1 in Quiescent Hepatic Stellate Cells (Cells, 2022)

  • 🧪 Telomere Length and Glutathione Level as Potential Biomarkers for Autism (J Psychi Res Rev Rep, 2021)

  • 🔗 Uncovering Multiple Protein Interaction Networks Linked to Fragile X Mental Retardation Protein (FEBS J., 2020)

  • 🛡️ FMRP Protects Against TNF-Mediated Cell Death and Liver Injury (Gut, 2020)

  • 📍 Subcellular Localization Reveals Direct Interaction of FMRP with Nucleolin (Manuscript)